FDA approves lower-cost alternative to biotech drug Humira
Federal regulators on Friday approved the first alternative version of the second-best selling drug in the world, Humira, the blockbuster injection used to treat rheumatoid arthritis and other inflammatory diseases.
Sep 23, 2016
0
3